Articles

Find an Article

Filter articles

Applied Filters

Showing 1381 to 1390 of 1469 results

Business brief 2011: Pakistan

Pakistan01-01-2011Hameeda Asif and Ayesha Hasan

Patent rights are governed by the Patents Ordinance, 2000, along with the Patents Rules, 2003.

Business brief 2011: South Africa

South Africa01-01-2011Christel Wolmarans and Herman Blignaut

Trademark rights can be divided into two categories, namely statutory rights and rights afforded by common law.

Business brief 2011: UK

01-01-2011Iona Harding and James Whymark

To secure a UK patent, applicants can apply to the UK Intellectual Property Office (IPO) or to the European Patent Office (EPO) designating the UK.

Business brief 2011: Venezuela

Venezuela01-01-2011Patricia Hoet-Limbourg

There haven’t been any significant changes or developments in Venezuela over the last year that IP professionals and owners need to be aware of.

Online issues at the ECJ

EU, Poland01-01-2011Anna Szajna and Maria Jurek

Since Poland’s accession to the EU, judgments of the Court of Justice of the European Union (ECJ) have been part of the Polish law and are applied directly with priority to national law. Anna Szajna and Maria Jurek take a look at the key cases.

AIPPI, Palais des Congrès, Paris

EPO01-12-2010

The 42nd AIPPI Intellectual Property Congress featured contributions from some of the most influential figures in IP and a lively debate among senior judges on the scope of patentability across jurisdictions.

Consumers first: GlaxoSmithKline on trademarks

01-12-2010

People often think that IP in the healthcare sector is all about patents. But while GlaxoSmithKline certainly has a patent portfolio to protect, it also takes a strident approach to enforcing its trademarks and defending its brands.

Back to basics: renewing the foundations of innovation

01-12-2010BiotechnologyJim Greenwood

The economic crisis has caused companies and governments alike to reassess their spending. Jim Greenwood explains why imperilling IP protection for the biotechnology industry would be the worst possible outcome.

ANDA one, ANDA too?

01-12-2010David K.S. Cornwell and Kevin W. McCabe

David Cornwell and Kevin McCabe describe the complex process for obtaining FDA approval for generic and biosimilar drugs, and managing patent disputes with approved companies.

Counterfeit medicines - the quintessential borderless crime

01-12-2010

The global spread of counterfeit pharmaceuticals presents a formidable challenge to public health. WIPR asked lawyers from Baker & McKenzie offices around the world about this growing menace and what IP rights owners can do.

Showing 1381 to 1390 of 1469 results

Directory

Service Providers

Mayora IP

Law Firms

The Luzzatto Group

Kyosei International Patent Office
Japan

Inventa
Portugal, EUIPO, EPO, ARIPO, OAPI, Angola, Mozambique, Nigeria, Cape Verde, São Tomé and Principe, Macau & East Timor

Regina Lex Attorneys
Barbados

Banwo & Ighodalo
Nigeria, Ghana, OAPI, ARIPO

Anaqua
United States

Sutton Magidoff Barkume LLP
USA

Chofn Intellectual Property
China

WIPR